Short communication: Human lymphotropic virus type 1 coinfection modulates the synthesis of cytokines by peripheral blood mononuclear cells from HIV type 1-infected individuals

AIDS Research and Human Retroviruses

Volumn 28, Issue 8, 2012, Pages 806-808

  Abrahão, Marcos H N ^a   Lima, Rosangela G ^a   Netto, Eduardo ^a   Brites, Carlos ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; PENICILLIN G; STREPTOMYCIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; MIXED INFECTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

CANDY; CELL CULTURE TECHNIQUES; CYTOKINES; HIV INFECTIONS; HIV-1; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKOCYTES, MONONUCLEAR;

EID: 84864194028     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2011.0192     Document Type: Article

References (17)

1. Cohen OJ and Fauci AS: Pathogenesis and medical aspects of HIV-1 infection. In: Fields Virology, Vol. 2 (Knipe DM, Howley PM, eds.). Lippincott Williams & Wilkins, Philadelphia, PA, 2000, pp. 2043-2094.
2. Edlich RF, Arnette JA, and Williams FM: Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I). J Emerg Med 2000;18:109-119.
3. Uchiyama T: Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol 1997;15:15-37.
4. Tajima K, Kamura S, Ito S, et al.: Epidemiological features of HTLV-I carriers and incidence of ATL in an ATL-epidemic island: A report of the community-based co-operative study in Tsushima, Japan. Int J Cancer 1987;40:741-746.
5. Brites C, Harrington W Jr, Pedroso C, Martins Netto E, and Badaró R: Epidemiological characteristics of HTLV-1 and II co-infection in brazilian subjects infected by HIV-1. Braz J Infect Dis 1997;1:42-47.
6. Casseb J, Caterino-de-Araujo A, Hong MA, et al.: Prevalence of HTLV-I and HTLV-II infections among HIV-1-infected asymptomatic individuals in Sao Paulo, Brazil. Rev Inst Med Trop Sao Paulo 1997;39:213-215.
7. Brites C, Alencar R, Gusmão R, et al.: Co-infection with HTLV-1 is associated with a shorter survival time for HIV-1- infected patients in Brazil. AIDS 2001;15:2053-2055.
8. Li JC, Yim HC, and Lau ASY: Tat in AIDS pathogenesis: its effects on cytokine dysregulation and contributions to the pathogenesis of opportunistic infection. AIDS 2010;24:1609-1623.
9. Carvalho EM, Bacellar O, Porto AF, et al.: Cytokine profile and immunomodulation in asymptomatic human T-lymphotropic virus type 1-infected blood donors. J Acquir Immune Defic Syndr 2001;27:1-6.
10. Montanheiro PA, Penalva De Oliveira AC, Smid J, et al.: The elevated interferon gamma production is an important immunological marker in HAM/TSP pathogenesis. Scand J Immunol 2009;70:403-407.
11. Schechter M, Moulton LH, and Harrison LH: HIV viral load and CD4+ lymphocyte counts in subjects coinfected with HTLV-1 and HIV-1. J Acquir Immune Defic Syndr 1997;15: 308-311.
12. Scapellato PG, Bottaro E, Rodriguez-Brieschke MT, et al.: CD4 cell count among HIV-infected patients with an AIDSdefining disease: Higher count in patients coinfected than in those not coinfected with human T-cell lymphotropic virus type I. J Acquir Immune Defic Syndr, 2003;33:279-280.
13. Brites C, Goyanna F, Franca LG, et al.: Coinfection by HTLVI/ II is associated with an increased risk of strongyloidiasis and delay in starting antiretroviral therapy for AIDS patients. Braz J Infect Dis 2011;15:6-11.
14. Regis C, Oliveira A, and Brites C: Onset of opportunistic infections in patients co-infected by HTLV-1 and HIV-1, with high CD4 + cells count. Braz J Infect Dis 2009;13: 311-313.
15. Chinen J and Shearer WT: Molecular virology and immunology of HIV infection. J Allergy Clin Immunol 2002; 110:189-198.
16. Gudo ES, Bhatt NB, Bila DR, et al.: Co-infection by human immunodeficiency vírus type 1 (HIV-1) and human T cell leukemia vírus type 1 (HTLV-1): Does immune activation lead to a faster progression to AIDS? BMC Infect Dis 2009;9:211-232.
17. Pedroso C, Netto EM, Weyll N, and Brites C: Coinfection by HIV-1 and human lymphotropic virus type 1 in children is strongly associated with a shorter survival time. J Acquir Immune Defic Syndr 2011;57:S208-S211.